title: Infliximab use in patients with Crohn's disease: quality of life, costs and resource use.
authors.affiliation: Department of Gastroenterology, University Medical Centre Utrecht, Utrecht, the Netherlands.
authors.forename: C
authors.initials: C
authors.lastname: Koelewijn
authors.forename: A
authors.initials: A
authors.lastname: Schrijvers
authors.forename: B
authors.initials: B
authors.lastname: Oldenburg
mesh_terms: D000911:Antibodies, Monoclonal / Q000191:economics / Q000627:therapeutic use*; D015331:Cohort Studies; D003424:Crohn Disease / Q000188:drug therapy* / Q000191:economics / Q000453:epidemiology; D016527:Drug Costs; D005060:Europe / Q000453:epidemiology; D005765:Gastrointestinal Agents / Q000191:economics / Q000627:therapeutic use*; D006295:Health Resources / Q000191:economics / Q000706:statistics & numerical data*; D006801:Humans; D000069285:Infliximab; D009656:North America / Q000453:epidemiology; D011788:Quality of Life; D016032:Randomized Controlled Trials as Topic
chemical_list: D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D000069285:Infliximab